August J. Troendle - Mar 6, 2024 Form 4 Insider Report for Medpace Holdings, Inc. (MEDP)

Role
CEO, Director, More than 10% owner
Signature
/s/ Stephen P. Ewald, Attorney-in-Fact for August J. Troendle
Stock symbol
MEDP
Transactions as of
Mar 6, 2024
Transactions value $
-$82,321,250
Form type
4
Date filed
3/8/2024, 05:08 PM
Previous filing
Mar 6, 2024
Next filing
May 1, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
transaction MEDP Common Stock -Sell -$41,298,000 -100,000 -2.03% $412.98 4,833,019 Mar 6, 2024 By Medpace Investors, LLC F1, F2, F3
transaction MEDP Common Stock -Sell -$30,805,500 -75,000 -1.55% $410.74 4,758,019 Mar 7, 2024 By Medpace Investors, LLC F1, F3, F4
transaction MEDP Common Stock -Sell -$10,217,750 -25,000 -0.53% $408.71 4,733,019 Mar 8, 2024 By Medpace Investors, LLC F1, F3, F5
holding MEDP Common Stock 806,643 Mar 6, 2024 Direct

Explanation of Responses:

Id Content
F1 The transactions reported on this Form 4 were effected pursuant to a limit order placed by Medpace Investors, LLC ("MPI") during an open window period.
F2 The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $406.36 to $419.42. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.
F3 The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
F4 The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $406.33 to $415.64. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.
F5 The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $402.90 to $414.195. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.